Cynthia A. Derdeyn
Affiliations: | Biological and Biomedical Sciences | Emory University, Atlanta, GA |
Area:
Immunology, Molecular Biology, Virology BiologyGoogle:
"Cynthia Derdeyn"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mopuri R, Welbourn S, Charles T, et al. (2023) High throughput analysis of B cell dynamics and neutralizing antibody development during immunization with a novel clade C HIV-1 envelope. Plos Pathogens. 19: e1011717 |
| Styles TM, Gangadhara S, Reddy PBJ, et al. (2022) V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques. Frontiers in Immunology. 13: 914969 |
| Sahoo A, Jones AT, Cheedarla N, et al. (2022) A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques. Science Immunology. 7: eabl4102 |
| Welbourn S, Chakraborty S, Yang JE, et al. (2022) A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence. Plos Pathogens. 18: e1010488 |
| Pino M, Pereira Ribeiro S, Pagliuzza A, et al. (2021) Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART. Plos Pathogens. 17: e1009825 |
| Charles TP, Burton SL, Arunachalam PS, et al. (2021) The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection. Plos Pathogens. 17: e1009257 |
| Arunachalam PS, Charles TP, Joag V, et al. (2020) T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers. Nature Medicine |
| McBrien JB, Mavigner M, Franchitti L, et al. (2020) Author Correction: Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8 cells. Nature |
| McBrien JB, Mavigner M, Franchitti L, et al. (2020) Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8 cells. Nature |
| Chamcha V, Reddy PBJ, Kannanganat S, et al. (2019) Strong T1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy. Science Translational Medicine. 11 |